Stay updated on Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. This appears to be a backend/frontend upgrade with no visible changes to study content or navigation.
    Difference
    0.1%
    Check dated 2026-03-21T20:17:03.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T08:49:39.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The revision label updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T16:22:49.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed, replacing v3.4.0 as the page revision. This is a minor metadata update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:34:48.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Only a minor revision update from v3.4.0 to v3.4.1 is shown, with no visible changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:33:34.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The changes are minor UI/metadata updates: a glossary display was added and QC/versioning labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) were updated, replacing previous lowercase/case variants. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T09:29:09.000Z thumbnail image

Stay in the know with updates to Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.